Cadmus to bring smart pharma packaging to US

By Gareth Macdonald

- Last updated on GMT

Related tags: Pharmacology

Packaging and printing specialist Cadmus is to start making an
intelligent pharmaceutical packaging with enhanced child-resistance
for clients in US the drug industry.

The Pharma discrete dose slider (DDS), which was originally developed by Finnish firm Stora Enso, is intended to improve both safety and treatment compliance. It features a child-proof locking mechanism that is also easy for seniors to operate as well as segmented single unit dose blister packaging compartments. The system also includes an embedded microchip, developed by Swedish technology specialist Cypak, which is designed to record the precise time and date that each pill is removed from its housing. The increasing use of highly toxic and high potency medications in the pharmaceutical industry, for indications ranging from cancer to HIV, means that in many cases drug packaging must serve as a containment system as much as a simple container. Additionally, with medical advances enabling more patients to live at home during treatment, away from direct medical supervision, smart packaging systems have a greater role to play in improving patient compliance. Tom McCrae, Cadmus' vice president of marketing and technical sales, told that the firm will target "pharmaceuticals companies for whom the correct balance between child-resistance and ease of access for seniors is a priority."​ McCrae added that Cadmus, which will manufacture the product at its facility in Charlotte, North Carolina, will supply the raw tear-resistant CKB Pharma TR board to pharmaceutical firms for further processing on their existing packaging lines. He declined to provide financial terms of Cadmus' licensing agreement with Stora or details of any prospective clients. "Cadmus' investment in the latest equipment allows for DDS to be cost competitive in CR compliance packaging​," says David Phillipes, Cadmus director of business development. "Cadmus' current exposure to the Pharmaceutical industry is expected to give additional boost and entry for sales of DDS​." Suitable for highly toxic drugs ​ Speaking at the time of Pharma DDS's launch in November last year, Ismo Saarinen, director of Stora Enso's Pharmaceutical Solutions division, said that the product had been successfully tested by a number of packaging machine manufacturers which had confirmed that the product was compatible with high speed cartoning machinery with only minor tooling modifications. Saarinen added that "based on very positive results in CR and SF testing, Pharma DDS addresses the requirements for a wide range of pharmaceutical packaging." ​He went on to say that the carton, which achieved the highest F-1 testing result in that it prevented children from accessing even a single dosage unit during protocol testing, is particularly suited for the packaging of highly toxic drugs

Related topics: Drug Delivery, Processing equipment

Related news

Show more

Related suppliers

Follow us


View more